SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes?
Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.
United States Simeoni Taylor Hojin Shin University Of Maryland Division Of Pharmacoepidemiology National Institute On
Source: medscape.com